Next up for CRISPR: Gene editing for the masses?
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
Stay updated with breaking news from Tania Bubela. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
Breaking News, Sports, Manitoba, Canada
Asking the hard questions about the COVID-19 response will require us to reflect on our own and systemic biases
Experts are calling for an independent national inquiry into Canada's COVID-19 response in articles published in the British Medical Journal
Data was not shared consistently between all levels of government during the crisis; a public inquiry should be called to address public health data issues